AquaBounty Technologies Stock Forecast, Price & News

+0.02 (+0.32 %)
(As of 04/14/2021 12:00 AM ET)
Today's Range
Now: $6.19
50-Day Range
MA: $6.88
52-Week Range
Now: $6.19
Volume1.30 million shs
Average Volume3.17 million shs
Market Capitalization$439.11 million
P/E RatioN/A
Dividend YieldN/A
AquaBounty Technologies, Inc., a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
AquaBounty Technologies logo

Industry, Sector and Symbol

Industry Fishing, hunting & trapping
Current SymbolNASDAQ:AQB
Year FoundedN/A



Sales & Book Value

Annual Sales$190,000.00
Book Value$1.10 per share


Net Income$-13,230,000.00
Net Margins-11,050.81%


Market Cap$439.11 million
Next Earnings Date5/4/2021 (Estimated)
OptionableNot Optionable


AquaBounty Hires Dennis Bryant as Director of Sales
April 6, 2021 |
Why AquaBounty Technologies Stock Fell Hard Today
March 24, 2021 |
AquaBounty Technologies (NASDAQ:AQB) Shares Down 10.7%
March 24, 2021 |
AquaBounty Technologies' Charts Aren't Going Swimmingly
March 24, 2021 |
AquaBounty Technologies (NASDAQ:AQB) Shares Up 3%
March 23, 2021 |
Why AquaBounty Technologies Stock Plunged Today
February 4, 2021 |
AquaBounty to Continue Swimming Against the Current
December 14, 2020 |
See More Headlines


Overall MarketRank

1.19 out of 5 stars

Medical Sector

920th out of 2,019 stocks

Fishing, Hunting & Trapping Industry

1st out of 5 stocks

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
+0.02 (+0.32 %)
(As of 04/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

Is AquaBounty Technologies a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than AquaBounty Technologies?

Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AquaBounty Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AquaBounty Technologies?

AquaBounty Technologies saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 3,060,000 shares, an increase of 65.4% from the February 28th total of 1,850,000 shares. Based on an average trading volume of 3,660,000 shares, the days-to-cover ratio is currently 0.8 days.
View AquaBounty Technologies' Short Interest

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for AquaBounty Technologies

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) posted its quarterly earnings results on Monday, March, 8th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by $0.05. AquaBounty Technologies had a negative trailing twelve-month return on equity of 36.77% and a negative net margin of 11,050.81%.
View AquaBounty Technologies' earnings history

How has AquaBounty Technologies' stock price been impacted by COVID-19?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AQB shares have increased by 234.6% and is now trading at $6.19.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AQB?

2 Wall Street analysts have issued 1-year price objectives for AquaBounty Technologies' stock. Their forecasts range from $3.50 to $9.00. On average, they expect AquaBounty Technologies' stock price to reach $5.83 in the next twelve months. This suggests that the stock has a possible downside of 5.8%.
View analysts' price targets for AquaBounty Technologies
or view top-rated stocks among Wall Street analysts.

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:
  • Ms. Sylvia A. Wulf, CEO, Pres & Exec. Director (Age 63, Pay $383.17k)
  • Mr. David A. Frank, CFO & Treasurer (Age 61, Pay $282.8k)
  • Dr. Alejandro Rojas, Chief Operating Officer of AquaBounty Farms (Age 59, Pay $234.1k)
  • Dr. Mark Walton, Chief Technology Officer
  • Ms. Angela M. Olsen J.D., Gen. Counsel & Corp. Sec. (Age 52)
  • Dave Conley, Director of Communications
  • Mr. David F. Melbourne Jr., Chief Commercial Officer
  • Mr. Louis H. Barnett, Financial Advisor

Who are some of AquaBounty Technologies' key competitors?

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $6.19.

How much money does AquaBounty Technologies make?

AquaBounty Technologies has a market capitalization of $439.11 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

How many employees does AquaBounty Technologies have?

AquaBounty Technologies employs 72 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is

Where are AquaBounty Technologies' headquarters?

AquaBounty Technologies is headquartered at 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]

This page was last updated on 4/14/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.